Skip to content
Evofem Biosciences, Inc.

Evofem Biosciences, Inc.

  • About Us
    • Mission
    • Management
    • Board of Directors
      • WILLIAM HALL, Ph.D., M.D.
      • Saundra Pelletier
      • GILLIAN GREER, CBE, Ph.D.
      • KIM P. KAMDAR, Ph.D.
      • Tony O’Brien
      • Lisa Rarick, MD, FACOG
      • Colin Rutherford
  • Our Product
    • phexxi®
  • Pipeline
    • In Development
    • Posters & Publications
    • Clinical Trials
  • Investors
    • Investor Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
    • Financial Information
      • SEC Filings
    • Analyst Coverage
    • Corporate Governance
      • Committee Composition
      • Board of Directors
      • Charters & Code of Ethics
    • Investor Resources
      • Investor Contact
      • Investor FAQs
  • Contact
    • Investor Contact
    • Media Contact
    • General Contact
    • Careers

SEC Filings

OTCQBEVFM
YearTrailing 12-MonthsCalendar Year 2024Calendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Mergers & AcquisitionsProxy & Information StatementsOther
FormDescriptionDateFormat

7770 Regents Rd. Suite 113-618
San Diego, California 92122
1.858.550.1900

Phexxi® and the Phexxi® logo are registered trademarks of Evofem Biosciences, Inc.

Quick Links

  • About Us
  • Phexxi ®
  • Pipeline

Contact

  • Investor
  • Media
  • General
  • Careers

© 2024 Evofem Biosciences, Inc.

  • Privacy Policy
  • Legal
  • Compliance